Skip to main content
. 2023 Jan 16;24(2):1772. doi: 10.3390/ijms24021772

Figure 3.

Figure 3

When treating tuberculosis infection with triple therapy, which includes isoniazid, rifampicin, and pyrazinamide, the level of NF-κB initially rises, which could assist with the clearance of the infection. However as the administration time continues with triple therapy, the level of NF-κB subsequently begins to decline after some time.